Debate Over Celestia Transparency and Funding Rounds

Latest reports indicate that the Celestia community is disappointed with the Celestia Foundation's latest over-the-counter (OTC) token sales.

Members of the Celestia community have expressed disappointment over the latest over-the-counter (OTC) token sales conducted by the Celestia Foundation.

According to critics within the community, these transactions were disguised as favorable news regarding funding, ultimately misleading regular investors into acquiring tokens, while internal team members and venture capital (VC) investors sold.

In a recent tweet, prominent crypto observer Ericonomic highlighted the ease with which Celestia could have ensured fairness during this capital raise.

According to Ericonomic, all that was required was the disclosure of the valuation, vesting, and whether the transaction was indeed an OTC sale, rather than a fundraising round.

The tweet further suggested that the team could have simply sold some tokens, or the foundation could have sold tokens, depending on the actual nature of the transaction.

This disclosure would have provided all stakeholders with a clear understanding of the project's financial activities, preventing any misunderstandings or dissatisfaction.

The biggest criticism is a lack of transparency, as the Celestia team failed to disclose that the transaction was an OTC sale rather than a true investment round.

This disclosure has created a debate over whether the foundation and its team should be more forthcoming about the valuation and specifics of such deals, ensuring that all stakeholders have a clear picture of the project’s financial activities.

This announcement comes shortly after Bain Capital Crypto led Celestia’s most recent fundraising round, which saw the project raise $100 million.

According to CNF, the large infusion of funds has boosted the Celestia Foundation’s overall funding to an astonishing $155 million, signifying a considerable increase in financial support for the project.

This has been interpreted as a sign of rising trust and interest in Celestia’s vision and technological advances.

On the other hand, as CNF reported in August, Celestia announced its first significant upgrade, “Lemongrass,” which aims to bring a slew of new features and advancements to the network. The Lemongrass upgrade introduces 1-click Tia interactions, Interchain accounts, and a new upgrading method.

These additions are expected to considerably improve the general usefulness and interoperability of the Celestia network, hence contributing to its developing ecosystem.

Meanwhile, Celestia’s native token, TIA, is now trading at $6.37, up 9.22% over the last seven days. The latest price jump has increased its market cap to be more than $1.3 billion.